MICRONIZED PROGESTERON IN COMPLEX PREGRAVID PREPARATION AND PREGNANCY MANAGEMENT IN WOMEN WITH RECURRENT PREGNANCY LOSS ON THE BACKGROUND OF CHRONIC ENDOMETRITIS
| Main Authors: | С. І. Жук, С. Б. Чечуга, О. А. Ночвіна |
|---|---|
| Format: | Article Journal |
| Bahasa: | ukr |
| Terbitan: |
, 2020
|
| Subjects: | |
| Online Access: |
https://zenodo.org/record/4281298 |
Daftar Isi:
- Purpose of the study: to determine the effectiveness of micronized progesterone with antibacterial therapy in the complex of pregravid training and during pregnancy in women with recurrent pregnancy loss on the background of chronic endometritis. Materials and methods. It was assessed the course of pregnancy and childbirth on clinical and instrumental grounds with a prospective analysis of reproductive losses in women with recurrent miscarriage and chronic endometritis. 45 pregnant women with recurrent miscarriage on the background of chronic endometritis formed the main group and were prospectively examined. Main group were divided into subgroups: I subgroup – 24 patients who were included in the study at the stage of perconception training; subgroup II – 21 patients who were included in the study with a diagnosed pregnancy for up to 12 weeks. The control group consisted of 32 pregnant women with a normal course of previous pregnancies without a history of reproductive loss. Results. Patients with recurrent miscarriage and chronic endometritis who received a complex of preconception training with support of the luteal phase with micronized progesterone showed a statistically significantly lower percentage of clinical symptoms of threatened abortion, with no significant difference in control group. Thus, only 2 (8.3%) patients lost pregnancy in the I subgroup who received the proposed preconception therapy, and 6 (28,5%) women lost pregnancy in the II subgroup who started taking micronized progesterone only from the moment of pregnancy diagnosed. Conclusions. Obtained results prove the effectiveness of the micronized progesterone (Utrogestan®) at the stage of pre-pregnancy training in women with recurrent pregnancy loss and chronic endometritis, as evidenced by the percentage of reproductive losses. The universality of routes of administration for micronized progesterone and possibility of its use throughout pregnancy contributes to individualize of treatment regimens